Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. More Details
Mediocre balance sheet and overvalued.
Share Price & News
How has Tonghua Golden-Horse Pharmaceutical Industry CoLtd's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 000766 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 000766's weekly volatility (8%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 000766 underperformed the CN Pharmaceuticals industry which returned 14.4% over the past year.
Return vs Market: 000766 underperformed the CN Market which returned 27.4% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Tonghua Golden-Horse Pharmaceutical Industry CoLtd's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Tonghua Golden-Horse Pharmaceutical Industry CoLtd undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 000766's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 000766's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 000766 is unprofitable, so we can't compare its PE Ratio to the CN Pharmaceuticals industry average.
PE vs Market: 000766 is unprofitable, so we can't compare its PE Ratio to the CN market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 000766's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 000766 is good value based on its PB Ratio (1.5x) compared to the CN Pharmaceuticals industry average (2.8x).
How is Tonghua Golden-Horse Pharmaceutical Industry CoLtd forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tonghua Golden-Horse Pharmaceutical Industry CoLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Tonghua Golden-Horse Pharmaceutical Industry CoLtd performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 000766 is currently unprofitable.
Growing Profit Margin: 000766 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 000766 is unprofitable, and losses have increased over the past 5 years at a rate of 65.6% per year.
Accelerating Growth: Unable to compare 000766's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 000766 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (10.9%).
Return on Equity
High ROE: 000766 has a negative Return on Equity (-94.13%), as it is currently unprofitable.
How is Tonghua Golden-Horse Pharmaceutical Industry CoLtd's financial position?
Financial Position Analysis
Short Term Liabilities: 000766's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥594.9M).
Long Term Liabilities: 000766's short term assets (CN¥1.8B) do not cover its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 000766's debt to equity ratio (84.9%) is considered high.
Reducing Debt: 000766's debt to equity ratio has increased from 14.6% to 84.9% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 000766 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 000766 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 42.4% per year.
What is Tonghua Golden-Horse Pharmaceutical Industry CoLtd current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 000766's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 000766's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 000766's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 000766's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 000766's dividend in 3 years as they are not forecast to pay a notable one for the CN market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Yanfeng Ji has been General Manager of Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. since December 2015.
Experienced Board: 000766's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's company bio, employee growth, exchange listings and data sources
- Name: Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
- Ticker: 766
- Exchange: SZSE
- Founded: 1990
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥3.769b
- Shares outstanding: 966.49m
- Website: https://www.thjm.cn
Number of Employees
- Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
- No. 999, Jinma Road
- Erdaojiang District
- Jilin Province
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products primarily focus on the rheumatism, diges...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/11 09:03|
|End of Day Share Price||2021/04/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.